Aldeyra Therapeutics - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeAldeyra Therapeutics
Aldeyra Therapeutics logo

Aldeyra Therapeutics

0 followers

ALDX

Performance

About Aldeyra Therapeutics

Aldeyra Therapeutics is a biotechnology company focused on developing next-generation medicines for immune-mediated and metabolic diseases. The company's mission is to enhance the well-being of patients by developing medications that target the inhibition of inflammatory cells associated with ocular and systemic ailments.

Recent News

No recent news for this company.

Recent Deals

Key Facts

HQ Location

Lexington, United States

Founded

2004

Employees

11 - 50

Status

Public

Website

https://aldeyra.com